Global surveillance and control of hepatitis C
Global surveillance and control of hepatitis C
复制标题
DOI：
10.1046/j.1365-2893.1999.6120139.x
复制
发表时间：
1999-01
影响因子：
2.5
通讯作者：
D. Lavanchy;R. Purcell;F. Hollinger;C. Howard;A. Alberti;M. Kew;G. Dusheiko;M. Alter;E. Ayoola;P. Beutels;R. Bloomer;B. Ferret;R. Decker;R. Esteban;O. Fay;H. Fields;E. Fuller;P. Grob;M. Houghton;N. Leung;S. Locarnini;H. Margolis;A. Meheus;T. Miyamura;M. Mohamed;B. Tandon;D. Thomas;H. T. Head;A. Toukan;P. Damme;A. Zanetti;R. Arthur;M. Couper;R. Amelio;J. Emmanuel;K. Esteves;P. Gavinio;E. Griffiths;Z. Hallaj;C. Heuck;D. Heymann;S. Holck;M. Kane;L. Martinez;F. Meslin;I. Mochny;A. Ndikuyeze;A. Padilla;G. Rodier;C. Roure;F. Savage;G. Vercauteren
中科院分区：
文献类型：
--
作者：
D. Lavanchy;R. Purcell;F. Hollinger;C. Howard;A. Alberti;M. Kew;G. Dusheiko;M. Alter;E. Ayoola;P. Beutels;R. Bloomer;B. Ferret;R. Decker;R. Esteban;O. Fay;H. Fields;E. Fuller;P. Grob;M. Houghton;N. Leung;S. Locarnini;H. Margolis;A. Meheus;T. Miyamura;M. Mohamed;B. Tandon;D. Thomas;H. T. Head;A. Toukan;P. Damme;A. Zanetti;R. Arthur;M. Couper;R. Amelio;J. Emmanuel;K. Esteves;P. Gavinio;E. Griffiths;Z. Hallaj;C. Heuck;D. Heymann;S. Holck;M. Kane;L. Martinez;F. Meslin;I. Mochny;A. Ndikuyeze;A. Padilla;G. Rodier;C. Roure;F. Savage;G. Vercauteren
丙型肝炎是由丙型肝炎病毒感染引起的全球性健康问题。虽然许多国家没有具有代表性的流行率数据，但现有数据表明，世界人口中约有3%感染了丙型肝炎病毒。据估计，全世界可能有多达1.7亿人感染丙型肝炎病毒。在许多国家，问题的确切程度和各种传播途径的相对贡献尚未通过基于人口的研究确定。在可能的情况下，应进行这种研究，使各国能够估计丙型肝炎疾病的负担，确定预防措施的优先次序，并最适当地利用现有资源。为了在全球范围内评估丙型肝炎，世界卫生组织（卫生组织）组织了一次国际专家磋商会，以审查与丙型肝炎感染有关的公共卫生问题，并就预防和控制丙型肝炎提出建议
Hepatitis C is a global health problem caused by infection with the hepatitis C virus. Although representative prevalence data are not available from many countries, available data indicate that approximately 3% of the world’s population is infected with HCV. It is estimated that as many as 170 million persons worldwide may be infected with HCV. In many countries, the exact magnitude of the problem and the relative contribution of the various routes of transmission have not been defined with population‐based studies. Wherever possible such studies should be performed to enable countries to estimate the burden of hepatitis C disease, to prioritize their preventative measures and to make the most appropriate use of available resources. To assess hepatitis C on a global scale, the World Health Organization (WHO) organized a consultation of international experts, in order to review the public health aspects related to hepatitis C infection and to make recommendations for its prevention and control